VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
GLMD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
GLMDGalmed Pharmaceuticals Ltd.
$0.57$3M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksGLMDQuarterly Financials

Galmed Pharmaceuticals Ltd. (GLMD) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Galmed Pharmaceuticals Ltd. (GLMD) quarterly income statement — complete revenue, gross profit & net income history

GLMD Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21Q1'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold00000000000000000000
COGS % of Revenue--------------------
Gross Profit00000000000000000000
Gross Margin %--------------------
Gross Profit Growth %--------------------
Operating Expenses3.04M2.1M2.11M1.26M1.64M2.01M1.22M1.4M2.15M1.47M1.87M2M2.45M5.38M3.73M6.09M7.49M7.84M8.41M9.13M
OpEx % of Revenue--------------------
Selling, General & Admin946K1.01M1.05M630K572K1.27M688K766K1.03M912K1.06M919K1.07M1.14M1.15M1.3M1.23M1.3M1.38M1.75M
SG&A % of Revenue--------------------
Research & Development2.1M1.09M1.06M634K1.07M738K534K635K1.12M556K809K1.08M1.38M4.24M2.58M4.8M6.26M6.54M7.04M7.38M
R&D % of Revenue--------------------
Other Operating Expenses00000000000000000000
Operating Income-3.04M-2.1M-2.11M-1.26M-1.64M-2.01M-1.22M-1.4M-2.15M-1.47M-1.87M-2M-2.45M-5.38M-3.73M-6.09M-7.49M-7.84M-8.41M-9.13M
Operating Margin %--------------------
Operating Income Growth %-85.04%-4.18%-72.59%9.78%23.57%-36.99%34.69%30.02%12.17%72.71%49.84%67.14%67.31%31.42%55.66%33.29%27.56%-3.36%-44.64%-41.32%
EBITDA-3.04M-2.1M-2.11M-1.26M-1.64M-2.01M-1.15M-1.39M-2.15M-1.46M-1.86M-1.99M-2.44M-5.37M-3.72M-6.08M-7.48M-7.83M-8.4M-9.12M
EBITDA Margin %--------------------
EBITDA Growth %-85.04%-4.18%-83.71%9.2%23.36%-37.74%38.35%30.19%12.09%72.82%49.96%67.22%67.39%31.43%55.71%33.31%27.58%-3.34%-44.69%-41.37%
D&A (Non-Cash Add-back)00000074K9K6K8K9K8K9K8K9K9K10K11K10K11K
EBIT-3.04M-2.1M-2.11M-1.26M-1.64M-2.01M-1.22M-1.4M-2.15M-1.47M-1.87M-2M-2.45M-5.38M-3.73M-6.09M-7.49M-7.84M-8.41M-9.13M
Net Interest Income411K203K140K160K-448K97K103K126K135K-5K278K172K-190K30K-4K-51K145K131K16K227K
Interest Income411K203K140K160K097K103K126K135K0278K172K030K00188K131K16K227K
Interest Expense0000448K00005K00190K04K51K43K000
Other Income/Expense-1.78M203K-386K160K-1.56M97K103K126K135K-5K278K172K-190K30K-4K-51K40K131K16K227K
Pretax Income-4.82M-1.89M-2.5M-1.1M-3.21M-1.91M-1.12M-1.27M-2.02M-1.47M-1.59M-1.83M-2.64M-5.35M-3.73M-6.14M-7.45M-7.71M-8.4M-8.9M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-4.82M-1.89M-2.5M-1.1M-3.21M-1.91M-1.12M-1.27M-2.02M-1.47M-1.59M-1.83M-2.64M-5.35M-3.73M-6.14M-7.45M-7.71M-8.4M-8.9M
Net Margin %--------------------
Net Income Growth %-50.14%1.15%-122.97%13.41%-59.18%-29.94%29.76%30.33%23.61%72.47%57.34%70.21%64.59%30.65%55.53%31.02%27.49%-11.72%-51.94%-46.87%
Net Income (Continuing)-4.82M-1.89M-2.5M-1.1M-3.21M-1.91M-1.12M-1.27M-2.02M-1.47M-1.59M-1.83M-2.64M-5.35M-3.73M-6.14M-7.45M-7.71M-8.4M-8.9M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.73-0.35-0.63-0.62-46.42-27.69-2.13-0.23-0.40-0.24-0.95-0.99-1.68-3.20-2.23-3.70-4.45-4.61-5.02-5.71
EPS Growth %98.43%98.74%70.42%-169.57%-11505%-11437.5%-124.21%76.77%76.19%92.5%57.4%73.24%62.25%30.59%55.58%35.2%37.76%5.34%-28.06%-32.79%
EPS (Basic)-0.73-0.35-0.63-0.62-46.42-27.69-2.13-0.23-0.40-0.24-0.95-0.99-1.68-3.20-2.23-3.70-4.46-4.61-5.02-5.71
Diluted Shares Outstanding6.58M5.46M3.95M1.78M1.61M69.13K524.56K5.46M5.05M6.25M1.68M1.68M1.68M1.68M1.67M1.67M1.67M1.67M1.67M1.56M
Basic Shares Outstanding6.58M5.46M3.95M1.78M1.61M69.13K524.56K5.46M5.05M6.25M1.68M1.68M1.68M1.68M1.67M1.67M1.67M1.67M1.67M1.56M
Dividend Payout Ratio--------------------